Incyte's First-In-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
Incyte's First-In-Class mutCALR-Targeted Monoclonal Antibody, IN…
3 months ago
marketscreener.com
Clinical Impact of CALR Mutation in Patients With Essential Thrombocythemia
Clinical Impact of CALR Mutation in Patients With Essential Thromboc…
Sep 23, 2024
vumedi.com
Incyte's Blood Cancer Drug Program 'Looks Very Viable' Amid Development Challenges, RBC Says
Incyte's Blood Cancer Drug Program 'Looks Very Viable' Amid Develop…
3 months ago
marketscreener.com
Incyte Gets FDA Fast Track For Rare Blood Cancer Drug
Incyte Gets FDA Fast Track For Rare Blood Cancer Drug
3 months ago
investors.com
Incyte Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody
1:15:36
Incyte Positive Data for INCA033989, its First-In-Class mutCALR-Target…
64 views3 months ago
YouTubeInvesting 101
Safety & efficacy of INCA033989, a first-in-class mutant CALR-specific mAb, in patients with ET & MF
2:06
Safety & efficacy of INCA033989, a first-in-class mutant CALR-specifi…
90 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
How Incyte Reached the 'Cutting Edge' of Cancer Research
How Incyte Reached the 'Cutting Edge' of Cancer Research
Jul 20, 2018
delawaretoday.com
1:28
What makes mutant CALR an attractive therapeutic target in MP…
136 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Incyte : des traitements prometteurs contre le cancer colorectal et panc…
4 months ago
zonebourse.com
0:58
Introducing the Incucyte® Live-Cell Analysis System: Antibody Intern…
887 viewsMay 10, 2023
YouTubeSartorius
1:46
The role of CALR mutations in the initiation and progression of MPNs
2.4K viewsNov 15, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
20:34
Targeting mutant CALR in MPNs with antibodies & cellular therapy…
70 views5 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:24
The promise of mutant CALR-targeting therapies in MPNs
125 views6 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Incyte Data at AACR 2025 | Incyte Medical
10 months ago
linkedin.com
1:16
Preliminary results from trials targeting mutant CALR for the trea…
198 views8 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:14
Targeting CALR mutations in MPNs: a promising novel immunotherape…
65 views4 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Incyte Sees IBD RS Rating Improve To 79
7 months ago
investors.com
2:33
Targeting CALR mutations in MPNs: type 1 versus type 2
370 views6 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:17
Targeting CALR with immunotherapy in MPNs
647 viewsJun 3, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:24
Incyte stock dives after drug trial disappoints investors
14.1K views1 year ago
YahooYahoo Finance Video
New Incyte bioplant opens in Switzerland - BioAlps
Sep 1, 2021
bioalps.org
2:00
Expression of CD47 and CALR in MPNs
310 viewsJun 10, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:05
Why is CALR an ideal immunotherapeutic target for MPN…
1.5K viewsNov 4, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:25
CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN)
7.5K viewsMay 9, 2014
YouTubeMayo Clinic Laboratories
Incyte CEO on the future of cancer treatment
Jun 5, 2017
CNBC
Incyte moves forward on expansion, announces cancer fund
Oct 6, 2017
delawareonline.com
Incyte Crashes. Why Its $750 Million Takeover Looks Kaput.
Nov 19, 2024
investors.com
Incyte seeks billions after worker allegedly walks off with cancer dr…
Oct 15, 2017
delawareonline.com
1:04
Introducing the Incucyte® Live-Cell Analysis System: Immunocytoche…
554 viewsMay 10, 2023
YouTubeSartorius
1:29
Incyte CEO Bill Meury: Blood cancer therapy development is company'…
2 months ago
MSNCNBC
See more videos
Static thumbnail place holder